Key statistics
As of last trade Transmedics Group Inc (8T8:DUS) traded at 118.50, -8.35% below its 52-week high of 129.30, set on Dec 02, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 121.25 |
|---|---|
| High | 121.25 |
| Low | 118.50 |
| Bid | 122.00 |
| Offer | 123.85 |
| Previous close | 119.95 |
| Average volume | 5.71 |
|---|---|
| Shares outstanding | 34.30m |
| Free float | 33.25m |
| P/E (TTM) | 30.51 |
| Market cap | 4.98bn USD |
| EPS (TTM) | 4.76 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 15:31 GMT.
More ▼
Press releases
- TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
- TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- TransMedics to Present at Upcoming March Investor Conferences
- TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
- TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
- TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
More ▼
